| For: | Chang S, Malter L, Hudesman D. Disease monitoring in inflammatory bowel disease. World J Gastroenterol 2015; 21(40): 11246-11259 [PMID: 26523100 DOI: 10.3748/wjg.v21.i40.11246] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i40/11246.htm |
| Number | Citing Articles |
| 1 |
Yoshihiro Tatsumi, Kazuki Kakimoto, Azusa Hara, Noboru Mizuta, Keijiro Numa, Naohiko Kinoshita, Kei Nakazawa, Ryoji Koshiba, Yuki Hirata, Kazuhiro Ota, Takako Miyazaki, Shiro Nakamura, Kayoko Sakagami, Shoko Arimitsu, Hiroaki Ito, Hiroki Nishikawa. Biomarkers for Monitoring of Changes in Disease Activity in Ulcerative Colitis. Journal of Clinical Medicine 2023; 12(22) doi: 10.3390/jcm12227165
|
| 2 |
Jared Matson, Sonia Ramamoorthy, Nicole E. Lopez. The Role of Biomarkers in Surgery for Ulcerative Colitis: A Review. Journal of Clinical Medicine 2021; 10(15) doi: 10.3390/jcm10153362
|
| 3 |
Grazyna Piotrowicz, Agnieszka Klufczyńska, Jacek Kowerzanow, Piotr Banaszkiewicz,, Grażyna Rydzewska. Crohn’s disease activity evaluation based on imaging studies and biomarkers. Gastroenterology & Hepatology: Open Access 2018; 9(2) doi: 10.15406/ghoa.2018.09.00292
|
| 4 |
Gabriele Dragoni, Tommaso Innocenti, Andrea Galli. Biomarkers of Inflammation in Inflammatory Bowel Disease: How Long before Abandoning Single-Marker Approaches?. Digestive Diseases 2021; 39(3) doi: 10.1159/000511641
|
| 5 |
Mariangela Manfredi, Lieve Van Hoovels, Maurizio Benucci, Riccardo De Luca, Carmela Coccia, Pamela Bernardini, Edda Russo, Amedeo Amedei, Serena Guiducci, Valentina Grossi, Xavier Bossuyt, Carlo Perricone, Maria Infantino. Circulating Calprotectin (cCLP) in autoimmune diseases. Autoimmunity Reviews 2023; 22(5) doi: 10.1016/j.autrev.2023.103295
|
| 6 |
Stanislaus Argeny, Anton Stift, Michael Bergmann, Martina Mittlböck, Svenja Maschke, Yushan Yang, Praminthra Chitsabesan, Stefan Riss. Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn’s disease. Wiener klinische Wochenschrift 2018; 130(11-12) doi: 10.1007/s00508-018-1322-3
|
| 7 |
Effects of anti–TNF-alpha therapy on hemoglobin levels and anemia in patients with inflammatory bowel disease. Digestive and Liver Disease 2020; 52(4) doi: 10.1016/j.dld.2019.11.019
|
| 8 |
. 2021; doi: 10.70675/bb11b654z3d5fz4707z83d9z658c62d93492
|
| 9 |
Gabriele Dragoni, Gert De Hertogh, Séverine Vermeire. The Role of Citrullination in Inflammatory Bowel Disease: A Neglected Player in Triggering Inflammation and Fibrosis?. Inflammatory Bowel Diseases 2021; 27(1) doi: 10.1093/ibd/izaa095
|
| 10 |
Maryam Salimi, Joseph Albert Karam, Matthew Willman, Jonathan Willman, Brandon Lucke-Wold, Shokoufeh Khanzadeh, Peyman Mirghaderi, Javad Parvizi. Neutrophil to Lymphocyte Ratio and Periprosthetic Joint Infection: A Systematic Review and Meta-Analysis. The Journal of Arthroplasty 2024; 39(3) doi: 10.1016/j.arth.2023.08.067
|
| 11 |
Y. González-Lama, J. Sanz, G. Bastida, J. Campos, R. Ferreiro, B. Joven, A. Gutiérrez, X. Juanola, B. Sicilia, R. Veroz, J.P. Gisbert, M. Chaparro, E. Domènech, M. Esteve, F. Gomollón. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el tratamiento de pacientes con espondiloartritis asociada a enfermedad inflamatoria intestinal. Enfermedad Inflamatoria Intestinal al Día 2017; 16(1) doi: 10.1016/j.eii.2016.09.002
|
| 12 |
Rui Zhou, Ying Chang, Jing Liu, Min Chen, Hongling Wang, Meifang Huang, Shi Liu, Xiaobing Wang, Qiu Zhao. JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4+ T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.00781
|
| 13 |
Francisco Guilherme Cancela Penna, Rodrigo Macedo Rosa, Fernando H. Pereira, Pedro Ferrari Sales Cunha, Stella Cristina S. Sousa, Teresa Cristina A. Ferrari, Carlos Cara, Maria de Lourdes A. Ferrari. Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease. Gastroenterología y Hepatología 2021; 44(2) doi: 10.1016/j.gastrohep.2020.04.015
|
| 14 |
Djuna C de Jong, Mark Löwenberg, Ioannis Koumoutsos, Shuvra Ray, Joel Mawdsley, Simon Anderson, Jeremy D Sanderson, Krisztina Gecse, Cyriel Y Ponsioen, Geert R D’Haens, Peter M Irving, Mark A Samaan. Validation and Investigation of the Operating Characteristics of the Ulcerative Colitis Endoscopic Index of Severity. Inflammatory Bowel Diseases 2019; 25(5) doi: 10.1093/ibd/izy325
|
| 15 |
Ammar H. Keshteli, Richa Chibbar, Melissa Silva, Karen Danois, Rosica Valcheva, Eytan Wine, Levinus A. Dieleman. Determinants of complementary and integrative medicine use in inflammatory bowel disease: a focus on probiotics, prebiotics, and fermentable dietary fibres. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1641767
|
| 16 |
David T Rubin, Joana Torres, Iris Dotan, Lan Terry Xu, Irene Modesto, John C Woolcott, Sean Gardiner, Bruce E Sands. An Insight into Patients’ Perspectives of Ulcerative Colitis Flares via Analysis of Online Public Forum Posts. Inflammatory Bowel Diseases 2024; 30(10) doi: 10.1093/ibd/izad247
|
| 17 |
Marie Stute, Martin Kreysing, Markus Zorn, Patrick Michl, Annika Gauss. Serum Amyloid A as a Potential Biomarker in Inflammatory Bowel Diseases, Especially in Patients with Low C-Reactive Protein. International Journal of Molecular Sciences 2024; 25(2) doi: 10.3390/ijms25021177
|
| 18 |
Susana Herrero-Rodríguez, Leticia Martín-Cordero, Raquel Mayordomo, Isabel Gálvez, Eduardo Ortega. Sex-based differences in the relationship between health-related quality of life, physical activity, and inflammatory markers in people with Crohn's disease. Gastroenterología y Hepatología 2026; 49(2) doi: 10.1016/j.gastrohep.2025.502494
|
| 19 |
Giovanni Grassi, Maria Elena Laino, Massimo Claudio Fantini, Giovanni Maria Argiolas, Maria Valeria Cherchi, Refky Nicola, Clara Gerosa, Giulia Cerrone, Lorenzo Mannelli, Antonella Balestrieri, Jasjit S. Suri, Alessandro Carriero, Luca Saba. Advanced imaging and Crohn’s disease: An overview of clinical application and the added value of artificial intelligence. European Journal of Radiology 2022; 157 doi: 10.1016/j.ejrad.2022.110551
|
| 20 |
Esma H. San, Angelique Egberts, Caroline W. Th. van Dijck - van Boetzelaer, Rachel L. West, Erwin C. Vasbinder. High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease. European Journal of Clinical Pharmacology 2024; 80(7) doi: 10.1007/s00228-024-03676-8
|
| 21 |
Bari Dane, Sean Duenas, Joseph Han, Thomas O'Donnell, Justin Ream, Shannon Chang, Alec Megibow. Crohn's Disease Activity Quantified by Iodine Density Obtained From Dual-Energy Computed Tomography Enterography. Journal of Computer Assisted Tomography 2020; 44(2) doi: 10.1097/RCT.0000000000000986
|
| 22 |
Kimberly L. Klages, Kristoffer S. Berlin, Jessica L. Cook, Mary E. Keenan, Katherine Semenkovich, Gabrielle G. Banks, Tiffany M. Rybak, Rachel L. Ankney, Kristina M. Decker, John R. Whitworth, Mark R. Corkins. Examining Risk Factors of Health-Related Quality of Life Impairments Among Adolescents with Inflammatory Bowel Disease. Behavioral Medicine 2021; 47(2) doi: 10.1080/08964289.2019.1676193
|
| 23 |
Majken Lindholm, Antonio Di Sabatino, Tina Manon-Jensen, Giuseppe Mazza, Gunvor I. Madsen, Paolo Giuffrida, Massimo Pinzani, Aleksander Krag, Morten A. Karsdal, Jens Kjeldsen, Joachim H. Mortensen. A Serological Biomarker of Laminin Gamma 1 Chain Degradation Reflects Altered Basement Membrane Remodeling in Crohn’s Disease and DSS Colitis. Digestive Diseases and Sciences 2022; 67(8) doi: 10.1007/s10620-021-07252-3
|
| 24 |
G. M. C. Adriaans, R. J. Almeida, D. Jonkers, T. van den Heuvel, A. G. L. Bodelier, M. J. Pierik. Analysis of biomarkers and composite scores in IBD patients using probabilistic fuzzy systems. 2022 IEEE International Conference on Fuzzy Systems (FUZZ-IEEE) 2022; doi: 10.1109/FUZZ-IEEE55066.2022.9882584
|
| 25 |
Jonathan Y. Xia, Chelsea Hepler, Peter Tran, Nathan J. Waldeck, Joseph Bass, Arthur Prindle. Engineered calprotectin-sensing probiotics for IBD surveillance in humans. Proceedings of the National Academy of Sciences 2023; 120(32) doi: 10.1073/pnas.2221121120
|
| 26 |
Ahmed Bahaa, Tamer Elbaz, Hesham Elmakhzangy, Mohammed Shehata, Dalia Abd El-Kareem, AbdelAziz Gaber, Mohamed B. Hashem, Maissa El Raziky. Assessment of IBD disease activity by Interleukin-6 and serum amyloid A in relation with fecal calprotectin and endoscopic indices. Arab Journal of Gastroenterology 2024; 25(3) doi: 10.1016/j.ajg.2024.07.003
|
| 27 |
Cristina Carretero, Franck Carbonnel, Marc Ferrante, Torben Knudsen, Nancy Van Lent, Alan J. Lobo, Lucian Negreanu, Ana Vojvodic, Salvatore Oliva. Monitoring established Crohn’s disease with pan-intestinal video capsule endoscopy in Europe: clinician consultation using the nominal group technique. Current Medical Research and Opinion 2021; 37(9) doi: 10.1080/03007995.2021.1940910
|
| 28 |
Olivier Benoit, Mathieu Faron, Nicolas Margot, Ben Creavin, Clotilde Debove, Emmanuel Tiret, Yann Parc, Jérémie H. Lefevre. C-Reactive Protein Values After Colorectal Resection: Can We Discharge a Patient With a C-Reactive Protein Value >100? A Retrospective Cohort Study. Diseases of the Colon & Rectum 2019; 62(1) doi: 10.1097/DCR.0000000000001216
|
| 29 |
Alaa El-Hussuna, Almuthe Christina Hauer, Tarkan Karakan, Valerie Pittet, Henit Yanai, Jalpa Devi, Jesus K Yamamoto-Furusho, Ali Reza Sima, Hailemichael Desalegn, Mutaz Idrees Sultan, Vishal Sharma, Hany Shehab, Lamya Mrabti, Natalia Queiroz, Anuraag Jena, Andy Darma, Karin Davidson, Nicolas Avellaneda, Muhammed Elhadi, April Roslani, Dakshitha Wickramasinghe, Carlo Angelo Cajucom, Shaji Sebastian. ECCO consensus on management of inflammatory bowel disease in low- and middle-income countries. Journal of Crohn’s and Colitis 2026; 20(1) doi: 10.1093/ecco-jcc/jjaf125
|
| 30 |
Beatriz Teixeira, Helena M. R. Gonçalves, Paula Martins-Lopes. Gut Feeling: Biomarkers and Biosensors’ Potential in Revolutionizing Inflammatory Bowel Disease (IBD) Diagnosis and Prognosis—A Comprehensive Review. Biosensors 2025; 15(8) doi: 10.3390/bios15080513
|
| 31 |
Samantha Conley, Sangchoon Jeon, Vanessa Lehner, Deborah D. Proctor, Nancy S. Redeker. Sleep Characteristics and Rest–Activity Rhythms Are Associated with Gastrointestinal Symptoms Among Adults with Inflammatory Bowel Disease. Digestive Diseases and Sciences 2021; 66(1) doi: 10.1007/s10620-020-06213-6
|
| 32 |
Francisco Guilherme Cancela Penna, Rodrigo Macedo Rosa, Fernando H. Pereira, Pedro Ferrari Sales Cunha, Stella Cristina S. Sousa, Teresa Cristina A. Ferrari, Carlos Cara, Maria de Lourdes A. Ferrari. Combined evaluation of fecal calprotectin and C-reactive protein as a therapeutic target in the management of patients with Crohn's disease. Gastroenterología y Hepatología (English Edition) 2021; 44(2) doi: 10.1016/j.gastre.2020.04.010
|
| 33 |
Nghia H Nguyen, Dominic Picetti, Parambir S Dulai, Vipul Jairath, William J Sandborn, Lucila Ohno-Machado, Peter L Chen, Siddharth Singh. Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic Review. Journal of Crohn's and Colitis 2022; 16(3) doi: 10.1093/ecco-jcc/jjab155
|
| 34 |
Vasile-Claudiu Mihai, Marius Lucian Savin, Ioana-Irina Rezuș, Vasile-Lucian Boiculese, Alina Ecaterina Jucan, Georgiana Sârbu, Carmen Atodiresei, Mihaela Dranga, Otilia Nedelciuc, Liliana Gheorghe, Cristina Cijevschi-Prelipcean, Cătălina Mihai. Beyond Inflammation: Sarcopenia and Disease Phenotype Predict Unfavourable Course in Crohn’s Disease—A Retrospective Observational Study. Biomedicines 2026; 14(8) doi: 10.3390/biomedicines14081855
|
| 35 |
Lydia C. T. Buer, Bjørn A. Moum, Milada Cvancarova, David J. Warren, Nils Bolstad, Asle W. Medhus, Marte L. Høivik. Real world data on effectiveness, safety and therapeutic drug monitoring of vedolizumab in patients with inflammatory bowel disease. A single center cohort. Scandinavian Journal of Gastroenterology 2019; 54(1) doi: 10.1080/00365521.2018.1548646
|
| 36 |
Sara Resende, Manuela F. Frasco, Paulo P. Freitas, M. Goreti F. Sales. Detection of serum calprotectin based on molecularly imprinted photonic hydrogels: A novel approach for IBD diagnosis. Biosensors and Bioelectronics: X 2023; 13 doi: 10.1016/j.biosx.2023.100313
|
| 37 |
Mohamed Saleh Ismail, Diane E Peters, Steven P Rowe, Ali Salavati, Sowmya Sharma, Robert Anders, Martin Pomper, Barbara S Slusher, Florin M Selaru. PSMA-Targeted PET Radiotracer [18F]DCFPyL as an Imaging Biomarker in Inflammatory Bowel Disease. Clinical and Experimental Gastroenterology 2023; doi: 10.2147/CEG.S404009
|
| 38 |
Carley Rusch, Matthew Beke, Carmelo Nieves, Volker Mai, Tamara Stiep, Tracy Tholanikunnel, Adolfo Ramirez-Zamora, Christopher W. Hess, Bobbi Langkamp-Henken. Promotion of a Mediterranean Diet Alters Constipation Symptoms and Fecal Calprotectin in People with Parkinson’s Disease: A Randomized Controlled Trial. Nutrients 2024; 16(17) doi: 10.3390/nu16172946
|
| 39 |
Mengting Liu, Wenjie Yang, Wenqi Zhu, Daojun Yu. Innovative applications and research advances of bacterial biosensors in medicine. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1507491
|
| 40 |
Tyler McKechnie, Zacharie Cloutier, Vicki Archer, Lily Park, Jay Lee, Luke Heimann, Ashaka Patel, Dennis Hong, Cagla Eskicioglu. Using preoperative C‐reactive protein levels to predict anastomotic leaks and other complications after elective colorectal surgery: A systematic review and meta‐analysis. Colorectal Disease 2024; 26(6) doi: 10.1111/codi.17017
|
| 41 |
Terry Li, Benjamin Click, Salam Bachour, Michael Sachs, Edward L. Barnes, Benjamin L. Cohen, Susell Contreras, Jordan Axelrad. Suboptimal Guideline Adherence and Biomarker Underutilization in Monitoring of Post-operative Crohn’s Disease. Digestive Diseases and Sciences 2023; 68(9) doi: 10.1007/s10620-023-08044-7
|
| 42 |
M. Pehrsson, M. S. Alexdóttir, M. A. Karsdal, P. Thakker, J.H. Mortensen. Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2023; 17(6) doi: 10.1080/17474124.2023.2212158
|
| 43 |
Liran Domachevsky, Haim Leibovitzh, Irit Avni-Biron, Lev Lichtenstein, Natalia Goldberg, Meital Nidam, David Groshar, Hanna Bernstine, Ofer Ben-Bassat. Correlation of 18F-FDG PET/MRE Metrics with Inflammatory Biomarkers in Patients with Crohn’s Disease: A Pilot Study. Contrast Media & Molecular Imaging 2017; 2017 doi: 10.1155/2017/7167292
|
| 44 |
Pasqua Letizia Pesole, Marina Liso, Rossella Donghia, Vito Guerra, Antonio Lippolis, Mauro Mastronardi, Palma Aurelia Iacovazzi. 90K/Mac-2 BP Is a New Predictive Biomarker of Response to Infliximab Therapy in IBD Patients. International Journal of Molecular Sciences 2023; 24(4) doi: 10.3390/ijms24043955
|
| 45 |
Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis. Scandinavian Journal of Gastroenterology 2022; 57(5) doi: 10.1080/00365521.2021.2022193
|
| 46 |
Sarah Baum, Kamron Hamedi, Caroline Loftus, Gannett Loftus, Emily-Rose Zhou, Sergio Arce. From Cytokines to Biomarkers: Mapping the Immunopathology of Inflammatory Bowel Disease. Cells 2025; 14(20) doi: 10.3390/cells14201589
|
| 47 |
Isaiah P. Schuster, Leslie Klyachman, Ramona Rajapakse, Farah Monzur. Inflammatory Bowel Disease. Clinical Gastroenterology 2021; doi: 10.1007/978-3-030-81780-0_4
|
| 48 |
Kaushik Kondubhatla, Ayush Kaushal, Ali Daoud, Hassan Shabbir, Jihan A Mostafa. Pro-Atherogenic Inflammatory Mediators in Inflammatory Bowel Disease Patients Increase the Risk of Thrombosis, Coronary Artery Disease, and Myocardial Infarction: A Scientific Dilemma. Cureus 2020; doi: 10.7759/cureus.10544
|
| 49 |
Stanley A. Cohen. Alas, Who and What Can We Trust? Patients, Parents, Surrogate Markers, or the Specific Carbohydrate Diet. Journal of Pediatric Gastroenterology and Nutrition 2017; 65(3) doi: 10.1097/MPG.0000000000001665
|
| 50 |
Lorenzo Bertani, Gian Paolo Caviglia, Luca Antonioli, Rinaldo Pellicano, Sharmila Fagoonee, Marco Astegiano, Giorgio Maria Saracco, Elisabetta Bugianesi, Corrado Blandizzi, Francesco Costa, Davide Giuseppe Ribaldone. Serum Interleukin-6 and -8 as Predictors of Response to Vedolizumab in Inflammatory Bowel Diseases. Journal of Clinical Medicine 2020; 9(5) doi: 10.3390/jcm9051323
|
| 51 |
Ryan Pereira, Sanam Soomro, Kamala Vanarsa, Jessica Castillo, Vinaika Maruvada, Subra Kugathasan, Chandra Mohan. 1000-plex antibody array proteomic screen uncovers PGRPS, Haptoglobin, Serpin A4 and Fibrinogen as potential stool biomarkers of pediatric inflammatory bowel disease. Clinical Immunology 2025; 276 doi: 10.1016/j.clim.2025.110495
|
| 52 |
Tadashi Ichimiya, Tomoe Kazama, Keisuke Ishigami, Yoshihiro Yokoyama, Yuki Hayashi, Satoshi Takahashi, Takao Itoi, Hiroshi Nakase, Emiko Mizoguchi. Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel disease. PLOS ONE 2023; 18(6) doi: 10.1371/journal.pone.0286415
|
| 53 |
Parul Tandon, Adam V. Weizman. Management of Inpatient Inflammatory Bowel Disease. 2022; doi: 10.1007/978-1-0716-1987-2_5
|
| 54 |
Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park. Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study. Intestinal Research 2019; 17(3) doi: 10.5217/ir.2018.00064
|
| 55 |
Catherine Colman, Marlene Stone, Alain Bitton. Inflammatory Bowel Disease Nursing Manual. 2019; doi: 10.1007/978-3-319-75022-4_6
|
| 56 |
Francisco Guilherme Cancela e Penna, Rodrigo Macedo Rosa, Pedro Ferrari Sales da Cunha, Stella Cristina Silva de Souza, Maria de Lourdes de Abreu Ferrari. Faecal calprotectin is the biomarker that best distinguishes remission from different degrees of endoscopic activity in Crohn’s disease. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-1183-x
|
| 57 |
Min Ju Kim, Mi-Rae Shin, Hak Joo Choi, Seong-Soo Roh. Study of the Effect and Underlying Mechanism of Enzyme-Treated Garlic Extract on a Lipopolysaccharide-Induced Acute Colitis Model. The Journal of Internal Korean Medicine 2023; 44(6) doi: 10.22246/jikm.2023.44.6.1243
|
| 58 |
Nathaniel A. Cohen, Tenzin Choden, Emma C. Dyer, Nicole M. Garcia, Natalie K. Choi, David T. Rubin. Utility of the Endoscopic Healing Index in Identifying Active Inflammation in Patients with Crohn’s Disease: Real World Data from a Tertiary Center. Digestive Diseases and Sciences 2024; 69(8) doi: 10.1007/s10620-024-08492-9
|
| 59 |
Adi Lahat, Ido Veisman. Capsule Endoscopy in Crohn’s Disease—From a Relative Contraindication to Habitual Monitoring Tool. Diagnostics 2021; 11(10) doi: 10.3390/diagnostics11101737
|
| 60 |
Ziheng Peng, Duo Xu, Yong Li, Xiaowei Liu, Fujun Li, Yu Peng. A novel role of prognostic nutritional index in predicting the effectiveness of infliximab in Crohn's disease. Annals of Medicine 2023; 55(1) doi: 10.1080/07853890.2023.2236011
|
| 61 |
Ruoran Shi, Fazheng Yu, Xueyu Hu, Yan Liu, Yuanyuan Jin, Honglin Ren, Shiying Lu, Jian Guo, Jiang Chang, Yansong Li, Zengshan Liu, Xiaoxu Wang, Pan Hu. Protective Effect of Lactiplantibacillus plantarum subsp. plantarum SC-5 on Dextran Sulfate Sodium—Induced Colitis in Mice. Foods 2023; 12(4) doi: 10.3390/foods12040897
|
| 62 |
Matthew K. Doherty, Tao Ding, Charlie Koumpouras, Shannon E. Telesco, Calixte Monast, Anuk Das, Carrie Brodmerkel, Patrick D. Schloss, Claire M. Fraser. Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients. mBio 2018; 9(2) doi: 10.1128/mBio.02120-17
|
| 63 |
Maria José Temido, Margarida Peixinho, Rosário Cunha, Andrea Silva, Sandra Lopes, Sofia Mendes, Ana Margarida Ferreira, Manuela Ferreira, Pedro Figueiredo, Francisco Portela. Plasma calprotectin as a biomarker of inflammatory activity in ulcerative colitis. Medicina Clínica 2025; 164(4) doi: 10.1016/j.medcli.2024.09.009
|
| 64 |
Jennifer C. Brazil, Charles A. Parkos. Finding the sweet spot: glycosylation mediated regulation of intestinal inflammation. Mucosal Immunology 2022; 15(2) doi: 10.1038/s41385-021-00466-8
|
| 65 |
Yoshikazu Tsuzuki, Rie Shiomi, Hisashi Matsumoto, Kazuya Miyaguchi, Takeru Kusano, Hideki Ohgo, Hidetomo Nakamoto, Hiroyuki Imaeda. Combined effects of granulocyte and monocyte adsorption apheresis and corticosteroids on ulcerative colitis. Journal of Clinical Biochemistry and Nutrition 2023; 72(1) doi: 10.3164/jcbn.22-52
|
| 66 |
Yi-Hao Che, Zheng-Yong Yu, Fu-Neng Geng, Miao He, Zhi-Bin Yang, Yuan-Yuan Zheng, Cheng-Gui Zhang, Yu Zhao, Xiu-Mei Wu, Heng Liu. Effects of the Traditional Chinese Medicine Formula Ento-PB in Experimental Models of Ulcerative Colitis. Natural Product Communications 2022; 17(3) doi: 10.1177/1934578X221078453
|
| 67 |
Yahya Ozel, H. Kubra Elcioglu, Z. Ayca Cevikelli, Ilyas Kudas, Sarfraz Ahmad, Hafize Uzun, Cumhur Topal, Serife Aktas, Levent Kabasakal. Ischemic colitis of the colon in streptozotocin-induced diabetic rats. Molecular and Cellular Biochemistry 2018; 439(1-2) doi: 10.1007/s11010-017-3138-2
|
| 68 |
Kamila Majidova, Julia Handfield, Kamran Kafi, Ryan D. Martin, Ryszard Kubinski. Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review. Genes 2021; 12(10) doi: 10.3390/genes12101465
|
| 69 |
Mustafa Ahmed, Ping Yuan, Jia-Geng Lei, Zhao-Ming Tang, Ze-Rui Yang, Lawrence A. Potempa, Hui-Ying Wang, Hai-Yun Li. From Homeostasis To Inflammation To Autoimmunity: The Potential Impact of CRP. Inflammation 2025; 48(6) doi: 10.1007/s10753-025-02303-7
|
| 70 |
Andres J Yarur, Michael V Chiorean, Julián Panés, Vipul Jairath, Jinkun Zhang, Christopher J Rabbat, William J Sandborn, Séverine Vermeire, Laurent Peyrin-Biroulet. Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial. Journal of Crohn's and Colitis 2024; 18(6) doi: 10.1093/ecco-jcc/jjae007
|
| 71 |
Glen Doherty, Konstantinos H Katsanos, Johan Burisch, Matthieu Allez, Konstantinos Papamichael, Andreas Stallmach, Ren Mao, Ingrid Prytz Berset, Javier P Gisbert, Shaji Sebastian, Jarosław Kierkuś, Loris Lopetuso, Edyta Szymanska, Edouard Louis. European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [‘Exit Strategies’] in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2018; 12(1) doi: 10.1093/ecco-jcc/jjx101
|
| 72 |
Claire Wang, Hannah M. Baer, Daniel R. Gaya, Robert J.B. Nibbs, Simon Milling. Can molecular stratification improve the treatment of inflammatory bowel disease?. Pharmacological Research 2019; 148 doi: 10.1016/j.phrs.2019.104442
|
| 73 |
Wojciech Marlicz, Karolina Skonieczna-Żydecka, Konstantinos John Dabos, Igor Łoniewski, Anastasios Koulaouzidis. Emerging concepts in non-invasive monitoring of Crohn’s disease. Therapeutic Advances in Gastroenterology 2018; 11 doi: 10.1177/1756284818769076
|
| 74 |
Petra Weimers, Dorit Vedel Ankersen, Pia Munkholm. Biomarkers in Inflammatory Bowel Diseases. 2019; doi: 10.1007/978-3-030-11446-6_22
|
| 75 |
Akshita Bhalla, Anushka Shahi , Madhurima Maity, FNU Safa, Vindlacheruvu Srividya, Ruchira Clementina, Goutham R Anugu, Salma Younas. Inflammatory Bowel Disease in Children: Current Diagnosis and Treatment Strategies. Cureus 2025; doi: 10.7759/cureus.78462
|
| 76 |
Zechariah Kandathil, Arif Raihan, Thivian Mathanaruban. Novel Therapeutic Strategies and Biomarkers in the Management of Inflammatory Bowel Disease: A Narrative Review. Cureus 2026; doi: 10.7759/cureus.113698
|
| 77 |
Kenny Chung, Catherine Colman, Marlene Stone, Alain Bitton. Inflammatory Bowel Disease Nursing Manual. 2025; doi: 10.1007/978-3-031-87503-8_6
|
| 78 |
Vladislav Volarevic, Natasa Zdravkovic, Carl Randall Harrell, Nebojsa Arsenijevic, Crissy Fellabaum, Valentin Djonov, Miodrag L. Lukic, Bojana Simovic Markovic. Galectin-3 Regulates Indoleamine-2,3-dioxygenase-Dependent Cross-Talk between Colon-Infiltrating Dendritic Cells and T Regulatory Cells and May Represent a Valuable Biomarker for Monitoring the Progression of Ulcerative Colitis. Cells 2019; 8(7) doi: 10.3390/cells8070709
|
| 79 |
Wu Yan, Wei Meihao, Song Zihan, Huang Lingjie, Chen Haotian, Cao Qian, Sun Lianli. Correlation Between Crohn's Disease Activity and Serum Selenium Concentration. Clinical Therapeutics 2022; 44(5) doi: 10.1016/j.clinthera.2022.03.005
|
| 80 |
Fatima Zahra Rahali, Nidae Mimouni, Abderrahman Boukhira, Saliha Chellak. The Clinical Utility of Standard and High-Sensitivity C-Reactive Protein: A Narrative Review. SN Comprehensive Clinical Medicine 2024; 6(1) doi: 10.1007/s42399-024-01693-3
|
| 81 |
Yuzhan Jin, Mingtao Ma, Yuqing Yan, Yaoyi Guo, Yue Feng, Chen Chen, Yi Zhong, Kaizong Huang, Huaming Xia, Yan Libo, Yanna Si, Jianjun Zou. A convenient machine learning model to predict full stomach and evaluate the safety and comfort improvements of preoperative oral carbohydrate in patients undergoing elective painless gastrointestinal endoscopy. Annals of Medicine 2023; 55(2) doi: 10.1080/07853890.2023.2292778
|
| 82 |
Isabelle Noiseux, Sophie Veilleux, Alain Bitton, Rita Kohen, Luc Vachon, Brian White Guay, John D. Rioux. Inflammatory bowel disease patient perceptions of diagnostic and monitoring tests and procedures. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0946-8
|
| 83 |
Alicja Derkacz, Paweł Olczyk, Agnieszka Jura-Półtorak, Krystyna Olczyk, Katarzyna Komosinska-Vassev. The Diagnostic Usefulness of Circulating Profile of Extracellular Matrix Components: Sulfated Glycosaminoglycans (sGAG), Hyaluronan (HA) and Extracellular Part of Syndecan-1 (sCD138) in Patients with Crohn’s Disease and Ulcerative Colitis. Journal of Clinical Medicine 2021; 10(8) doi: 10.3390/jcm10081722
|
| 84 |
Kano Matsuo, Masaki Ikemoto, Kohki Okada. Intraperitoneal Administration of S100A8 Ameliorates Experimental Acute Colitis in Rats. Biology 2024; 13(11) doi: 10.3390/biology13110916
|
| 85 |
Josko Bozic, Roko Santic, Piero Marin Zivkovic, Marko Kumric. Diet, Gut Microbiome, and Microbial Metabolites in Inflammatory Bowel Disease: From Functional Dysbiosis to Precision Nutrition. International Journal of Molecular Sciences 2026; 27(12) doi: 10.3390/ijms27125262
|
| 86 |
Thomas Dietze, Friedrich Anger, Daniel Bredenkötter, Christoph-Thomas Germer, Stefan Heinrich, Thea Höschel, Christoph Jänig, Maria Köhl, Uwe Krausbauer, Diana Sauer, Klaus Völker, Julia Wenzel, Jan Wittstamm. Notfälle in der Allgemein- und Viszeralchirurgie. 2019; doi: 10.1007/978-3-662-53557-8_28
|
| 87 |
Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihiro Fujiya, Kitaro Futami, Keisuke Hata, Fumihito Hirai, Sakiko Hiraoka, Tadakazu Hisamatsu, Ryota Hokari, Shunji Ishihara, Soichiro Ishihara, Michio Itabashi, Yoichi Kakuta, Jun Kato, Shingo Kato, Takehiko Katsurada, Kazuya Kitamura, Kiyonori Kobayashi, Taku Kobayashi, Kazutaka Koganei, Atsuo Maemoto, Toshiyuki Matsui, Takayuki Matsumoto, Katsuyoshi Matsuoka, Minoru Matsuura, Satoshi Motoya, Masakazu Nagahori, Makoto Naganuma, Yuji Naito, Shiro Nakamura, Hiroshi Nakase, Haruhiko Ogata, Kazuichi Okazaki, Hirotake Sakuraba, Masayuki Saruta, Shinichiro Shinzaki, Ken Sugimoto, Akira Sugita, Yasuo Suzuki, Kenichi Takahashi, Tomohisa Takagi, Kento Takenaka, Ken Takeuchi, Kiichiro Tsuchiya, Tomoyuki Tsujikawa, Motoi Uchino, Fumiaki Ueno, Kenji Watanabe, Mamoru Watanabe, Takayuki Yamamoto, Kaoru Yokoyama, Atsushi Yoshida, Naoki Yoshimura. Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021. Journal of Gastroenterology 2023; 58(4) doi: 10.1007/s00535-023-01958-z
|
| 88 |
Satoshi Motoya, Kenji Watanabe, Haruhiko Ogata, Takanori Kanai, Toshiyuki Matsui, Yasuo Suzuki, Mitsuhiro Shikamura, Kenkichi Sugiura, Kazunori Oda, Tetsuharu Hori, Takahiro Araki, Mamoru Watanabe, Toshifumi Hibi, John Green. Vedolizumab in Japanese patients with ulcerative colitis: A Phase 3, randomized, double-blind, placebo-controlled study. PLOS ONE 2019; 14(2) doi: 10.1371/journal.pone.0212989
|
| 89 |
Meyya Bouazzi, Nina F. Bak, Jørgen Agnholt, Vibeke Wewer, Mikkel Malham, Mia Bendix, Jimmy K. Limdi. Paediatric Crohn’s Disease Patients Have Increased Inflammatory Markers Compared to Adult Patients prior to Biological Treatment. GastroHep 2022; 2022 doi: 10.1155/2022/9550908
|
| 90 |
Fabien Beaufils, Emmanuel Mas, Marie Mittaine, Martin Addra, Michael Fayon, Laurence Delhaes, Haude Clouzeau, François Galode, Thierry Lamireau, Stéphanie Bui, Raphaël Enaud. Increased Fecal Calprotectin Is Associated with Worse Gastrointestinal Symptoms and Quality of Life Scores in Children with Cystic Fibrosis. Journal of Clinical Medicine 2020; 9(12) doi: 10.3390/jcm9124080
|
| 91 |
Gökhan Tonkaz, Hasan Hüseyin Can, Esma ÇINAR, Özgür Önal, Mehmet Tonkaz, Serdar Aslan, Duygu Erkal, Gökhan Aydın, Aykut Güruf, Ahmet Yasin Yitik. Relationship between sacroiliac joint involvement and intestinal disease activity in newly diagnosed Crohn’s disease. BMC Gastroenterology 2026; 26(1) doi: 10.1186/s12876-026-05122-8
|
| 92 |
Wenjing Hou, Gang Shu, Junzi Zhou, Cai Zhang, Ke Xiang, Xi Wei, Shao-Kai Sun, Jinbin Pan. Visualizing Microvascular
Remodeling for Precise Staging
of Inflammatory Bowel Disease via Ultralow-Dose Magnetic Resonance
Enterography. ACS Nano 2026; 20(37) doi: 10.1021/acsnano.6c05323
|
| 93 |
Enhui Ji, Tingting Wang, Jing Xu, Jianwei Fan, Yi Zhang, Yongxia Guan, Hongjun Yang, Junying Wei, Guimin Zhang, Luqi Huang. Systematic Investigation of the Efficacy of Sinitang Decoction Against Ulcerative Colitis. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01337
|
| 94 |
Aria Zand, Audrey Nguyen, Zack Stokes, Welmoed van Deen, Amy Lightner, Anya Platt, Rutger Jacobs, Sarah Reardon, Ellen Kane, Jonathan Sack, Daniel Hommes. Patient Experiences and Outcomes of a Telehealth Clinical Care Pathway for Postoperative Inflammatory Bowel Disease Patients. Telemedicine and e-Health 2020; 26(7) doi: 10.1089/tmj.2019.0102
|
| 95 |
Eleni Orfanoudaki, Ioannis Drygiannakis, Eirini Theodoraki, Kalliopi Foteinogiannopoulou, Aikaterini Mantaka, Ioannis E. Koutroubakis. Real-life utility and diagnostic accuracy of a home-performed fecal calprotectin test to predict endoscopic activity in patients with inflammatory bowel disease under maintenance treatment with adalimumab. European Journal of Gastroenterology & Hepatology 2021; 33(1S) doi: 10.1097/MEG.0000000000002248
|
| 96 |
Michael W. Winter, Joel V. Weinstock. The Autoimmune Diseases. 2020; doi: 10.1016/B978-0-12-812102-3.00046-4
|
| 97 |
Cristina Carretero, Alejandro Bojorquez, Rami Eliakim, Nikolaos Lazaridis. Updates in the diagnosis and management of small-bowel Crohn's disease. Best Practice & Research Clinical Gastroenterology 2023; doi: 10.1016/j.bpg.2023.101855
|
| 98 |
Maria José Temido, Margarida Peixinho, Rosário Cunha, Andrea Silva, Sandra Lopes, Sofia Mendes, Ana Margarida Ferreira, Manuela Ferreira, Pedro Figueiredo, Francisco Portela. Plasma calprotectin as a biomarker of inflammatory activity in ulcerative colitis. Medicina Clínica (English Edition) 2025; 164(4) doi: 10.1016/j.medcle.2024.09.015
|
| 99 |
Michelle Stakenborg, Bram Verstockt, Elisa Meroni, Gera Goverse, Veronica De Simone, Sare Verstockt, Mario Di Matteo, Paulo Czarnewski, Eduardo J Villablanca, Marc Ferrante, Guy E Boeckxstaens, Massimiliano Mazzone, Séverine Vermeire, Gianluca Matteoli. Neutrophilic HGF-MET Signalling Exacerbates Intestinal Inflammation. Journal of Crohn's and Colitis 2020; 14(12) doi: 10.1093/ecco-jcc/jjaa121
|
| 100 |
Emma Buchan, Pola Goldberg Oppenheimer. Review–Vibrational spectroscopy‐aided diagnosis, prognosis and treatment of inflammatory bowel disease. Clinical and Translational Discovery 2023; 3(5) doi: 10.1002/ctd2.249
|
| 101 |
Imen Tanniche, Bahareh Behkam. Engineered live bacteria as disease detection and diagnosis tools. Journal of Biological Engineering 2023; 17(1) doi: 10.1186/s13036-023-00379-z
|
| 102 |
Ulf Helwig. Pflege bei chronisch-entzündlichen Darmerkrankungen. 2023; doi: 10.1007/978-3-662-64938-1_7
|
| 103 |
Natae Fekadu Lemessa, Laith R. Sultan, Santiago Martinez-Correa, Laura May Davis, Misun Hwang. Expanding Role of Contrast-Enhanced Ultrasound and Elastography in the Evaluation of Abdominal Pathologies in Children. Diagnostics 2025; 15(13) doi: 10.3390/diagnostics15131680
|
| 104 |
Thomai Tsapanou-Katranara, Marta S. Alexdottir, Majken Lindholm Olesen, Viktor Domislović, Anne-Christine Bay-Jensen, Morten Asser Karsdal, Željko Krznarić, Jens Kjeldsen, Mark A. Ainsworth, Joachim H. Mortensen. Neutrophil-mediated degradation of type III collagen is elevated in inflammatory bowel disease and DSS-induced colitis reflecting early mucosal damage. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-09043-6
|
| 105 |
Lior Mor-Sasson, Chen Sarbagili-Shabat, Shiri Sherf-Dagan, Shira Zelber-Sagi, Nathaniel Aviv Cohen, Yulia Ron, Ayal Hirsch, Tamar Thurm, Nitsan Maharshak, Naomi Fliss-Isakov. Adherence to a Mediterranean dietary pattern is associated with biochemical remission in patients with Crohn's disease. Clinical Nutrition 2025; 53 doi: 10.1016/j.clnu.2025.07.036
|
| 106 |
Melissa Furtado, Ryan J. Van Lieshout, Michael Van Ameringen, Sheryl M. Green, Benicio N. Frey. Biological and psychosocial predictors of anxiety worsening in the postpartum period: A longitudinal study. Journal of Affective Disorders 2019; 250 doi: 10.1016/j.jad.2019.02.064
|
| 107 |
Majken Lindholm, Line E. Godskesen, Tina Manon-Jensen, Jens Kjeldsen, Aleksander Krag, Morten A. Karsdal, Joachim H. Mortensen. Endotrophin and C6Ma3, serological biomarkers of type VI collagen remodelling, reflect endoscopic and clinical disease activity in IBD. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-94321-2
|
| 108 |
Eleni Orfanoudaki, Maria Gazouli, Kalliopi Foteinogiannopoulou, Eirini Theodoraki, Evangelia Legaki, Ioannis Romanos, Ioannis Mouzas, Ioannis E. Koutroubakis. Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab. European Journal of Gastroenterology & Hepatology 2019; 31(2) doi: 10.1097/MEG.0000000000001332
|
| 109 |
Andrea Cejudo-Garcés, Jalpa Patel, Ana Jarén, Marta Maia Boscá-Watts, Sara Calatayud, María Dolores Barrachina, Dolores Ortiz-Masiá, Jesús Cosín-Roger. Decanoic acid in Crohn’s disease-associated complications: Antifibrotic effect mediated by PPARγ. Biomedicine & Pharmacotherapy 2026; 198 doi: 10.1016/j.biopha.2026.119294
|
| 110 |
Susana Herrero-Rodríguez, Leticia Martín-Cordero, Raquel Mayordomo, Isabel Gálvez, Eduardo Ortega. Sex-based differences in the relationship between health-related quality of life, physical activity, and inflammatory markers in people with Crohn's disease. Gastroenterología y Hepatología (English Edition) 2026; 49(2) doi: 10.1016/j.gastre.2025.502494
|
| 111 |
Sachin Kadian, Sarath Gopalakrishnan, Vidhya Selvamani, Sadid Khan, Trevor Meyer, Rithu Thomas, Muhammad Masud Rana, Pedro P. Irazoqui, Mohit S. Verma, Rahim Rahimi. Smart Capsule for Targeted Detection of Inflammation Levels Inside the GI Tract. IEEE Transactions on Biomedical Engineering 2024; 71(5) doi: 10.1109/TBME.2023.3343337
|
| 112 |
Marta Kramer Mikkelsen, Nana Aviaja Frederikke Lindblom, Anne Dyhl-Polk, Carsten Bogh Juhl, Julia Sidenius Johansen, Dorte Nielsen. Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer. Critical Reviews in Clinical Laboratory Sciences 2022; 59(7) doi: 10.1080/10408363.2022.2050886
|
| 113 |
Shonit Nair Sharma, Yuhan Lee. Monitoring homeostasis with ultrasound. Science 2024; 383(6687) doi: 10.1126/science.ado2145
|
| 114 |
Jason Orlando Dimitri Musci, Jack Stephen Cornish, Jan Däbritz. Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseases. Journal of Gastroenterology 2016; 51(6) doi: 10.1007/s00535-016-1191-3
|
| 115 |
Sebastian Fuchs, Nadia Sawas, Nicolas Staedler, David A. Schubert, Annalisa D'Andrea, Robert Zeiser, Luca Piali, Petr Hruz, Andreas P. Frei. High‐dimensional single‐cell proteomics analysis identifies immune checkpoint signatures and therapeutic targets in ulcerative colitis. European Journal of Immunology 2019; 49(3) doi: 10.1002/eji.201847862
|
| 116 |
Vishal Sharma, Suhang Verma, Praveen Kumar-M, Harshal S. Mandavdhare, Harjeet Singh, Jimil Shah, Dimple Kalsi, Amitava Dutta, Shubhra Mishra, Kaushal K. Prasad, Arun K. Sharma, Usha Dutta. Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn’s disease in patients started on antitubercular therapy. European Journal of Gastroenterology & Hepatology 2021; 33(3) doi: 10.1097/MEG.0000000000001879
|
| 117 |
Jie Chen, Xuejie Chen, Yuhao Sun, Ying Xie, Xiaoyan Wang, Ran Li, Therese Hesketh. The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic review. BMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02003-0
|
| 118 |
Jun Pan, Jiao Li, Yuanjun Gao. The value of 7 peripheral blood serum ratios in diagnosis and prediction of disease activity of patients within inflammatory bowel disease individuals. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1122005
|
| 119 |
Arta Aliu, Daan H. C. A. Bosch, Daniel Keszthelyi, Ashkan Rezazadeh Ardabili, Jean‐Frederic Colombel, Rachel Sawyer, Hans Törnblom, Ailsa Hart, Daisy M. A. E. Jonkers, Marieke J. Pierik, Zlatan Mujagic. Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission. Alimentary Pharmacology & Therapeutics 2024; 59(12) doi: 10.1111/apt.17988
|
| 120 |
Piotr Eder, Kamila Stawczyk-Eder, Katarzyna Korybalska, Natasza Czepulis, Joanna Luczak, Liliana Lykowska-Szuber, Iwona Krela-Kazmierczak, Krzysztof Linke, Janusz Witowski. Trefoil factor-3 is not a useful marker of mucosal healing in Crohn's disease treated with anti-TNF-α antibodies. World Journal of Gastroenterology 2017; 23(1): 135-140 doi: 10.3748/wjg.v23.i1.135
|
| 121 |
Riccardo Mager, Giulia Roda, Mohammad Khaled Shalaby, Stefania Vetrano. Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors. Current Drug Targets 2021; 22(2) doi: 10.2174/1389450121666201020160803
|
| 122 |
Alessandro Vitello, Marcello Maida, Endrit Shahini, Fabio Salvatore Macaluso, Ambrogio Orlando, Mauro Grova, Daryl Ramai, Gaetano Serviddio, Antonio Facciorusso. Current Approaches for Monitoring of Patients with Inflammatory Bowel Diseases: A Narrative Review. Journal of Clinical Medicine 2024; 13(4) doi: 10.3390/jcm13041008
|
| 123 |
Ting Zhang, Hang Zhong, Lu Lin, Zhiyan Zhang, Kewen Xue, Feixiang He, Yingshu Luo, Panpan Wang, Zhi Zhao, Li Cong, Pengfei Pang, Xiaofeng Li, Hong Shan, Zhixiang Yan. Core microbiome-associated proteins associated with ulcerative colitis interact with cytokines for synergistic or antagonistic effects on gut bacteria. The ISME Journal 2024; 18(1) doi: 10.1093/ismejo/wrae146
|
| 124 |
Kourosh Masnadi Shirazi, Simin Sotoudeh, Arman Masnadi Shirazi, Seyyed-Yaghoub Moaddab, Zahra Nourpanah, Zeinab Nikniaz. Effect of N-acetylcysteine on remission maintenance in patients with ulcerative colitis: A randomized, double-blind controlled clinical trial. Clinics and Research in Hepatology and Gastroenterology 2021; 45(4) doi: 10.1016/j.clinre.2020.08.010
|
| 125 |
Yuko Okuyama, Yosuke Doi, Naoto Matsuyama, Michiyo Uchino, Takayuki Yamamoto. A novel sol particle immunoassay for fecal calprotectin in inflammatory bowel disease patients. Clinica Chimica Acta 2016; 456 doi: 10.1016/j.cca.2016.02.012
|
| 126 |
José Fernando Vera Chamorro, Claudia Sánchez Franco, Melquicedec Vargas Sandoval, Diana Victoria Mora Quintero, Juan Pablo Riveros López, Fernando Sarmiento Quintero, Catalina Ortiz-Piedrahita, Otto Gerardo Calderón-Guerrero, Hugo Laignelet, Claudia Liliana Losada Gómez, Diana Paola Sánchez, Rocío del Pilar López Panqueva, Wilmer Aponte Barrios, Gustavo Adolfo Triana Rodríguez, Adriana Osorno, Luis Miguel Becerra Granados, María Claudia Ortega López, Óscar Correa Jiménez, Silvia Juliana Maradei Anaya, Mary García Acero, Ana María Acevedo Forero, Adriana Prada, Luis Carlos Ramírez Urrego, Lina Karina Salcedo Castilla, Andrés Enríquez, María Alejandra Suárez Fuentes, Natalia González Leal, Stephania Peña Hernández, Lina Sotaquirá Guáqueta, Francisco Sosa, Fernando Fierro, Santiago Correa, Francisco Javier Martín de Carpi. Consenso colombiano de la enfermedad inflamatoria intestinal pediátrica. Revista colombiana de Gastroenterología 2023; 38(Supl No. 1) doi: 10.22516/25007440.943
|
| 127 |
Jimil Shah, Manik Lal Thakur, Usha Dutta. Mucosal healing in inflammatory bowel disease: Expanding horizon. Indian Journal of Gastroenterology 2019; 38(2) doi: 10.1007/s12664-019-00950-x
|
| 128 |
M. Nedim Ince, David E. Elliott. Effective Use of the Laboratory in the Management of Patients with Inflammatory Bowel Diseases. Gastroenterology Clinics of North America 2019; 48(2) doi: 10.1016/j.gtc.2019.02.006
|
| 129 |
Marcello Candelli, Laura Franza, Giulia Pignataro, Veronica Ojetti, Marcello Covino, Andrea Piccioni, Antonio Gasbarrini, Francesco Franceschi. Interaction between Lipopolysaccharide and Gut Microbiota in Inflammatory Bowel Diseases. International Journal of Molecular Sciences 2021; 22(12) doi: 10.3390/ijms22126242
|
| 130 |
Rebecca L. Smith, Kirstin M. Taylor, Antony B. Friedman, David J. Gibson, Danny Con, Peter R. Gibson. Early sonographic response to a new medical therapy is associated with future treatment response or failure in patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 2022; 34(6) doi: 10.1097/MEG.0000000000002367
|
| 131 |
Carley Rusch, Matthew Beke, Lily Tucciarone, Katherine Dixon, Carmelo Nieves, Volker Mai, Tamara Stiep, Tracy Tholanikunnel, Adolfo Ramirez-Zamora, Christopher W Hess, Bobbi Langkamp-Henken. Effect of a Mediterranean diet intervention on gastrointestinal function in Parkinson’s disease (the MEDI-PD study): study protocol for a randomised controlled trial. BMJ Open 2021; 11(9) doi: 10.1136/bmjopen-2021-053336
|
| 132 |
Mohamed Shawky Abd Elall, Ashraf Abdelmegid Elfakhry, Mohamed Ali Atwa, Fatma Adel Abozeid. Correlation between nutritional status and plasma levels of ghrelin and leptin in inflammatory bowel disease patients. International Journal of Noncommunicable Diseases 2026; doi: 10.4103/jncd.jncd_231_25
|
| 133 |
Marijana Miler, Nora Nikolac Gabaj, Ivana Ćelap, Simeon Grazio, Vedran Tomašić, Alen Bišćanin, Joško Mitrović, Lovorka Đerek, Jadranka Morović-Vergles, Nada Vrkić, Mario Štefanović. Association of polymorphisms in promoter region of TNF-α -238 and -308 with clinical outcomes in patients with immune-mediated inflammatory diseases on anti-TNF therapy. Rheumatology International 2021; 41(12) doi: 10.1007/s00296-021-05016-w
|
| 134 |
Shubhra MISHRA, Sant RAM, Kaushal K PRASAD, Arun K SHARMA, Usha DUTTA, Vishal SHARMA. SERUM PROCALCITONIN AS A PROGNOSTIC MARKER IN ACUTE SEVERE ULCERATIVE COLITIS: A PROSPECTIVE STUDY. Arquivos de Gastroenterologia 2022; 59(1) doi: 10.1590/s0004-2803.202200001-14
|
| 135 |
A. S. Strik, S. J. A. Bots, G. D’Haens, M. Löwenberg. Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease. Expert Review of Clinical Pharmacology 2016; 9(3) doi: 10.1586/17512433.2016.1133288
|
| 136 |
Oliver Grundmann. Gastrointestinal Inflammation and the Gut Microbiome: An Evolving Conceptual Framework with Implications for Diagnosis and Therapy in Inflammatory Bowel Disorders. EMJ Microbiology & Infectious Diseases 2020; doi: 10.33590/emjmicrobiolinfectdis/20-00050
|
| 137 |
Ashish Dua, Vishal Sharma, Pankaj Gupta. Dual energy computed tomography in Crohn’s disease: a targeted review. Expert Review of Gastroenterology & Hepatology 2022; 16(8) doi: 10.1080/17474124.2022.2105203
|
| 138 |
Marie Vibeke Vestergaard, Kristine H. Allin, Gry J. Poulsen, James C. Lee, Tine Jess. Characterizing the pre-clinical phase of inflammatory bowel disease. Cell Reports Medicine 2023; 4(11) doi: 10.1016/j.xcrm.2023.101263
|
| 139 |
Ashley Vachon, Frank I. Scott. The treatment approach to inflammatory bowel disease in 2020. Current Opinion in Gastroenterology 2020; 36(4) doi: 10.1097/MOG.0000000000000653
|
| 140 |
Cristian Tefas, Radu Mărginean, Valentin Toma, Bobe Petrushev, Petra Fischer, Marcel Tanțău, Rareș Știufiuc. Surface-enhanced Raman scattering for the diagnosis of ulcerative colitis: will it change the rules of the game?. Analytical and Bioanalytical Chemistry 2021; 413(3) doi: 10.1007/s00216-020-03036-2
|
| 141 |
Cristiano Pagnini, Maria Benedetta Mariani, Vito Domenico Corleto, Gianfranco Delle Fave. Elevated C-Reactive Protein in Asymptomatic Crohnʼs Disease Patients. Inflammatory Bowel Diseases 2017; 23(3) doi: 10.1097/MIB.0000000000001030
|
| 142 |
Saemundur Jon Oddsson, Thrudur Gunnarsdottir, Lilja Gudrun Johannsdottir, Maria Lovisa Amundadottir, Arna Frimannsdottir, Pauliina Molander, Anna Karoliina Ylanne, Anna Sigridur Islind, Maria Oskarsdottir, Tryggvi Thorgeirsson. A New Digital Health Program for Patients With Inflammatory Bowel Disease: Preliminary Program Evaluation. JMIR Formative Research 2023; 7 doi: 10.2196/39331
|
| 143 |
Lorenzo Bertani, Brigida Barberio, Marco Fornili, Luca Antonioli, Federico Zanzi, Cesare Casadei, Laura Benvenuti, Sonia Facchin, Vanessa D'Antongiovanni, Greta Lorenzon, Linda Ceccarelli, Laura Baglietto, Nicola de Bortoli, Massimo Bellini, Francesco Costa, Edoardo Vincenzo Savarino, Matteo Fornai. Serum oncostatin M predicts mucosal healing in patients with inflammatory bowel diseases treated with anti-TNF, but not vedolizumab. Digestive and Liver Disease 2022; 54(10) doi: 10.1016/j.dld.2022.03.008
|
| 144 |
Robert H. Mills, Yoshiki Vázquez-Baeza, Qiyun Zhu, Lingjing Jiang, James Gaffney, Greg Humphrey, Larry Smarr, Rob Knight, David J. Gonzalez, Marcus J. Claesson. Evaluating Metagenomic Prediction of the Metaproteome in a 4.5-Year Study of a Patient with Crohn's Disease. mSystems 2019; 4(1) doi: 10.1128/msystems.00337-18
|
| 145 |
Rahul Kalla, Ray Boyapati, Simen Vatn, Gonzalo Hijos, Benjamin Crooks, Gregory Thomas Moore, Veronica Hall, George Lipscomb, Fernando Gomollón, Jørgen Jahnsen, Salil Singh. Patients’ perceptions of faecal calprotectin testing in inflammatory bowel disease: results from a prospective multicentre patient-based survey*. Scandinavian Journal of Gastroenterology 2018; 53(12) doi: 10.1080/00365521.2018.1527394
|
| 146 |
Bhaskar Gurram, Ashish S. Patel. Recent advances in understanding and managing pediatric inflammatory bowel disease. F1000Research 2019; 8 doi: 10.12688/f1000research.19609.1
|
| 147 |
Fang Liu, Seul A. Lee, Stephen M. Riordan, Li Zhang, Lixin Zhu. Global Studies of Using Fecal Biomarkers in Predicting Relapse in Inflammatory Bowel Disease. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.580803
|
| 148 |
Qiong Hu, Xing-zhou Tang, Fang Liu, De-wu Liu, Bo Cao. Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231166227
|
| 149 |
Marisa Iborra, Belén Beltrán, Pilar Nos. Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 2016; 26(4) doi: 10.1016/j.giec.2016.06.005
|
| 150 |
Yael Ross, Stanley Ballou. Reliability of C-reactive protein as an inflammatory marker in patients with immune-mediated inflammatory diseases and liver dysfunction. Rheumatology Advances in Practice 2023; 7(2) doi: 10.1093/rap/rkad045
|
| 151 |
. 2022; doi: 10.70675/0dba764dz2abfz44d6zb67czc9e4e3c2a77b
|
| 152 |
Ting Zhang, Bota Cui, Pan Li, Zhi He, Chuyan Long, Lu Wei, Zhaoyuan Peng, Guozhong Ji, Faming Zhang, John Green. Short-Term Surveillance of Cytokines and C-Reactive Protein Cannot Predict Efficacy of Fecal Microbiota Transplantation for Ulcerative Colitis. PLOS ONE 2016; 11(6) doi: 10.1371/journal.pone.0158227
|
| 153 |
Kiran K. Motwani, Madeline Alizadeh, Ameer Abutaleb, Jennifer Grossman, Jennifer Wellington, Raymond K. Cross, Kirk Russ, Meena Bewtra, James Lewis, Raymond Cross, Uni Wong, Scott Snapper, Josh Korzenik, Shrinivas Bishu, Rick Duerr, Sumona Saha, Freddy Caldera, Laura Raffals, Richa Shukla, Themistocles Dassopoulos, Matthew Bohm, Poonam Beniwal-Patel, David Hudesman, Lauren Brook, Joel Pekow, Elizabeth Scoville, Matthew A. Ciorba, Parakkal Deepak. Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn’s Disease and Ulcerative Colitis. Digestive Diseases and Sciences 2024; 69(6) doi: 10.1007/s10620-024-08421-w
|
| 154 |
Olga Maria Nardone, Uday Nagesh Shivaji, Vittoria Ferruzza, Subrata Ghosh, Marietta Iacucci. Soluble Blood Markers of Mucosal Healing in Inflammatory Bowel Disease: The Future of Noninvasive Monitoring. Inflammatory Bowel Diseases 2020; 26(6) doi: 10.1093/ibd/izz226
|
| 155 |
Małgorzata Szczuko, Paulina Komisarska, Justyna Kikut, Arleta Drozd, Diana Sochaczewska. Calprotectin Is Associated with HETE and HODE Acids in Inflammatory Bowel Diseases. Journal of Clinical Medicine 2023; 12(24) doi: 10.3390/jcm12247584
|
| 156 |
Suja P. Davis, Linda P. Bolin, Patricia B. Crane, Holly Wei, Jamie Crandell. Non-pharmacological interventions to manage fatigue in adults with inflammatory bowel disease: A systematic review and meta-analysis. Complementary Therapies in Clinical Practice 2020; 41 doi: 10.1016/j.ctcp.2020.101229
|
| 157 |
Jessica Gadsby, Karen Hall, Fathima Shah, Sanjeev Pattni, Sharon Gethins, Hussain Mulla. Infliximab: a single-centre, prospective, observational evaluation of TDM data in patients with IBD. European Journal of Hospital Pharmacy 2024; 31(1) doi: 10.1136/ejhpharm-2021-003015
|
| 158 |
Gichang Kim, Mi Jang, Inguk Hwang, Jeongyong Cho, Saehun Kim. Radish sprout alleviates DSS-induced colitis via regulation of NF-kB signaling pathway and modifying gut microbiota. Biomedicine & Pharmacotherapy 2021; 144 doi: 10.1016/j.biopha.2021.112365
|
| 159 |
Way Seah Lee, Katsuhiro Arai, George Alex, Suporn Treepongkaruna, Kyung Mo Kim, Chee Liang Choong, Karen Calixto Mercado, Andy Darma, Anshu Srivastava, Marion M. Aw. Management and monitoring of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerations. Journal of Gastroenterology and Hepatology 2023; 38(4) doi: 10.1111/jgh.16084
|
| 160 |
Ibrahimhalil Dusunceli, Zeynep Gok Sargin, Umut Celik, Fatih Sargin. The ability of C-reactive protein-albumin ratio to predict disease activity in ulcerative colitis. Biomarkers in Medicine 2025; 19(4) doi: 10.1080/17520363.2025.2459596
|
| 161 |
Mariusz Olczyk, Agnieszka Frankowska, Marcin Tkaczyk, Anna Socha-Banasiak, Elżbieta Czkwianianc. Early Symptoms in Children with Inflammatory Bowel Disease: Implications for Subsequent Bone Mineral Deficiency. Children 2024; 11(10) doi: 10.3390/children11101223
|
| 162 |
Yu Da, Fang Wang, Jiaqi Zhang, Tiantian Zhang, Xiaoning Liu, Jindan He, Yanting Shi, Tong Wu, Jie Liang. What is the optimal timing to assess the effect of 5-ASA in patients with mild-to-moderate ulcerative colitis? A single-center prospective observational study. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-04661-w
|
| 163 |
Katelin Durham, Tyler Atagozli, David E. Elliott, M. Nedim Ince. Laboratory Tests in Inflammatory Bowel Disease: An Evidence-Based Approach to Daily Practice. Biomedicines 2025; 13(2) doi: 10.3390/biomedicines13020491
|
| 164 |
Almuthe Christine Hauer, Mutaz Sultan, Andy Darma, Eyad Altamimi, Daniela Elena Serban, Amit Assa, Claudia Patricia Sánchez Franco, Lissy de Ridder, David C. Wilson, Nadeem Ahmad Afzal, Jiri Bronsky, Miglena Georgieva, Marina Aloi, Vaidotas Urbonas, Víctor Manuel Navas‐López, Juan Rivera Medina, Dan Turner, Jorge Amil‐Dias. Management of pediatric inflammatory bowel diseases in limited‐resource settings: A position paper from the Paediatric IBD Porto Group of ESPGHAN. Journal of Pediatric Gastroenterology and Nutrition 2025; 81(3) doi: 10.1002/jpn3.70121
|
| 165 |
Alicja Derkacz, Pawel Olczyk, Katarzyna Komosinska-Vassev. Diagnostic Markers for Nonspecific Inflammatory Bowel Diseases. Disease Markers 2018; 2018 doi: 10.1155/2018/7451946
|